chapter seven - shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/42130/12/12_chapter 7.pdf ·...
TRANSCRIPT
e*
Chapter Seven
e
e-f.eI?.a
irei!Sfwa
7. REFERENCES
Abdou, H.M. (1989). Theory of dissolution. In: Gennaro, A., Migdalof, B., Hassert, G.I.,
Medwick, T. (Eds.), Dissolution, bioavailability and bioequivalence, Mack
publishing, Pennsylvania, pp. 11-36.
Ain, Q., Shamia, S. and Khullar, O.K. (2003). Chemotherapeutic potential o f orally
administered poly (DL-lactide-co-glycolide) microparticles containing isoniazid,
rifampicin and pyrazinaniide against experimental tuberculosis. Antimicrob.
Agents Chemother., 47, 3005-3007.
Ain, Q., Sharma, S., Garg, S.K., and Khullar, G.K. (2003). Roll of Poly (DL-lactide-co-
glycolide) in development of a sustained oral drug delivery system for
antitubercular drug(s). Int. J. Pharm., 239, 37-46.
Al-Musa, S., Fara, D.A., Badwan, A.A. (1999). Evaluation of parameters involved in
preparation and release of drug loaded in cross-linked matrices of alginate. J.
Control. Release, 57 (3), 223-232.
Ammouiy, N., Fessi, H., Devissaguet, J.P., Dubrasquet, M. and Benita, S, (1991). Jejuna
absorption, pharmacological activity and pharaiacokinetic evaluation o f poly (d,l-
lactide) and poly (isobutylcyanoacrylate) nanocapsules in rats. Phami. Res., 8,
101-105.
Anderson, J.W., Allgood, L.D., Lawrence, A., Altringer, L.A„ Jerdack, G.R., Hengehold,
D.A. (2000b). Cholesterol-lowering effects of psyllium intake adjunctive to diet
therapy in men and women with hypercholesterolemia: meta-analysis o f 8
controlled trials. Am. I Clin. Nutr., 71,472-479.
Anderson, J.W., Allgood, L.D., Turner, J., Oeltgen, P.R., Daggy, B.P. (1999). Effects of
psyllium on glucose and semm lipid responses in men with type-2 diabetes and
hypercholesterolemia. Am. J. Clin, Nutr., 7 0 ,466-473.
Anderson, J.W., Davidson, M.H., Blonde, L., Brown, W.V., Howard, W.J., Ginsberg, H.,
Allgood, L.D., Weingand, K.W. (2000a). Long term cholesterol-lowering effects
Chapter 7 ____ ____________________________________________ References
Jamia Hamdard 226
of psyllium as an adj unct to diet therapy in the treatment o f hypercholesterolemia.
Am. J. Clin. Nutr., 71,1433-1438.
Anderson, J.W., O ’Neal, D.S., Riddell-Mason, S., Floore, T.L., Dillon, D.W., Oeltgen, P.R.
(1995). Postprandial serum glucose, insulin, and lipoprotein responses to high-
and low-fiber diets. Metabolism, 44, 848-854.
Babu, V.B.M., Khar, R.K. (1990). In vitro and In vivo studies o f sustained release floating
dosage forms containing salbutamol sulphate, Pharmazie, 45, 268-270.
Baker, B.W., Lonsdale, H.K, (1987). Controlled release of biological active agents. Wiley,
New York, pp. 15-71.
Banfi, E,, Scialino, G., Monti-Bragadin, C, (2003). Development of microdilution method to
evaluate Mycobaterium tuberculosis drug susceptibility. J. Antimicrob.
Chemother., 52, 796-800.
Blumenthal, M., Goldberg, A., Brinkmann, J. (2000). Herbal Medicine, Expanded
Commission E Monographs CD-Rom. American Botanical Council, Integrativ
Medicine, Austin, TX.
Bouchoucha, M., Faye, A,, Savarieau, B,, Arsac, M. (2004). Effect of an oral bulking agent
and a rectal laxative administered alone or in combination for the treatment o f
constipation. Gastroenterol. Clin. Biol., 28,438-443.
Bums, S.J., Attwood, D., Barnwell, S.G. (1998). Assessment o f a dissolution vessel designed
for use with floating and erodible dosage forms. Int, J. Pharm,, 160,213-218.
Central tuberculosis division (CTD), (1997).Revised National TB Control Programme.
Technical guidelines for TB Control. Central TB Division Directorate General o f
Health Services Ministry of Health and Family Welfare, New Delhi, pp 37-39
Centres for Disease Control. (1994). Tuberculosis care guide: Highlights from core
curriculum on tuberculosis. Department of Health and Human Services, Division of
Tuberculosis Elimination, Atlanta, Georgia, USA, pp. 639-1819.
Chapter 7 .........
Jamia Hamdard 227
Chang, R.K., Peng, Y., Shukla, A.J, (2005), Pharmaceutical Excipients. Edited by: Raymond
C. Rowe, Paul J. Sheskey and Sian C, Owen, pp, 1470-1488.
Chen, J.L. and Cyr, G.N. (1970). In: R.S. Manly (Ed.), Adhesion in biological systems,
Academic Press, New York, pp. 163-181.
Chickering, D.E., Jacob, J.S., Mathowitz, E. (1995). Bioadhesive microspheres II:
Characterisation and evaluation of bioadhesion involving hard, bioerodible
polymers and soft tissue. React. Polyra., 25,189-206.
Chitnis, V,, Malshe, V.S., Lalla, J.K. (1991). Bioadhesive polymers synthesis, evaluation and
application in controlled release tablets. Drug. Dev. Ind. Pharm., 17, 879-892.
Chiu, H.C., Hsiue, G.H., Lee, Y.P., Huang, L.W. (1999). Synthesis and characterization of
pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system.
J. Biomater. Sci. Polym. Ed., 10, 591-608.
Ch'ng, H.S., Park, H., Kelly, P, and Robinson, J.R. (1985). Bioadhesive polymers as
platforms for oral controlled drug delivery II: Synthesis and evaluation o f some
swelling, water-insoluble bioadhesive polymers. J. Pharni. Sci., 74 (4), 399-405.
Chourasia, M.K., Jain, S.K. (2003). Pharmaceutical approaches to colon targeted drug
delivery systems. J. Pharm, Pharm. Sci., 6, 33-66,
Chourasia, M.K., Jain, S.K. (2004). Polysaccharides for colon targeted drug delivery. Drug
Deliv,, 11, 129-148.
Chowdary, K.P.R, Srinivas, L, (2000). Mucoadhesive Drug delivery systems: A review of
current status. Indian Drugs, 27(9), 400-406.
Costa, P. and Lobo, J.M.S. (2001). Modelling and comparison of dissolution profile. Eur. J.
Pharm,, 13,123-133.
Couveur, P,, Lnarts, V., Kante, B,, Roland, M. and Speiser, P. (1980). Oral and parenteral
administration of insulin associated to hydrolysable nanoparticles. Acta. Pharm.
Technol., 26, 220-222.
_____________ _________________ References
Jamia Hamdard 22d
Cui, Fu-de., Yang, Ming-shi., Jiang, Yanyan,, Cun, Dongmei., Lin, Wenliui., Fan, Yuling.,
Kawashima, Yoshialci. (2003). Design o f sustained-release nitrendipine
microspheres having solid dispersion structure by quasi-emulsion solvent
diffLision method. J. Control. Release, 91, 375-384.
Currie, A.J., and Tervey, J.R. (1982). An enzymic method for the assay of D- Mannuronan-
C5- epimerase activity. Carbohydrate Res., 107(1), 165-169.
Dahl, TC. (2005). Pharmaceutical Excipients. Edited by: Raymond C. Rowe, Paul J. Sheskey
and Sian C. Owen. 737-753.
Danige, C., Defontaine, M., Aprahamian, M., Michael, C., Humbert, W. and Devissaguet, J.P.
(1991). Preferential uptake of nanocapsules through Payer’s patches in the rat.
Proceed, of the is"’ Symp. Control. Release Bioact. Mater., Amsterdam, pp. 349-
350.
Das, A.R., Dattagupta, N., Sridhar, C.N., and Wu, W.K. (2003). A novel thiocationic
liposomal formulation of antinsense oligonucleotides with activity against
Mycobacterium tuberculosis, Scand. J. Infect. Dis., 35, 168-174.
Derjaguin, B.V. and Smiiga, V.P.( 1966). In: Adhesion: Fundamentals and practice
proceedings, The Ministry of Technology, Gordon and Breach Science Publishers,
Univ. of Nottingham, pp. 152.
Derjaguin, B.V., Toporov, Y.P., Muller, V.M. and Aleinikova, LN. (1977). On the
relationship between the electrostatic and molecular component o f the adhesion of
elastic particles to a solid surface, J. Colloid Interface Sci., 58, 528-533.
Devissaguet, J.P., Fessi, H., Ammoury, N. and Barratt, G. (1992). Colloidal drug delivery
systems for gastrointestinal application. In: Drug targeting and delivery (Concepts
in dosage fonn deign), Junginger, H.E. (Eds.), Ellis H aw ood Ltd., West Sussex,
England, pp 71-91.
Dubey, R.R., Parikh, R.H. (2004). Two stage optimization process for formulation of chitosan
microspheres. AAPS PharmSciTech, 5 (1) Article 5
(http://www,aapspharmscitech.org).
Chapter 7 References
aJamia Hamdard 229
Duchene, D., Toucliard, E. and Peppas, N.A. (1988). Pharmaceutical and medicinal systems
for drug administration. Dmg Dev. Ind. Pliarm., 14, 283-318.
Dutt, M., and Khullar, G.K. (2000). Liposomes and poly (DL-iactide-co-glycolide)
microparticles as sustained release antitubercular drug carriers- an in vitro and in
vivo study. Int. J. Antimicrob. Agents, 18, 245-252,
Dutt, M., and Khullar, G.K. (2000). Poly (DL-lactide-co-glycolide) microparticles as carriers
for antimycobacterial drug rifampicin. Ind. J. Exp. Biol, 38, 887-894.
Dutt, M., and Khullar, G.K. (2001). Chemotherapy o f Mycobacterium tuberculosis infection
in mice with a combination of isoniazid and rifampicin entrapment in poly (DL-
lactide-co-glycolide) microparticles. J. Antimicrob. Chemother., 47, 829-835.
Dutta, S., Karki, R., Shivananda, P. G., Udupa, N. (2000). Liposome encapsulated rifampicin
and isoniazid. Ind. J. Pharm. Sci., 62 (5), 384-387.
Eldridge, J.H., Hammond, C.J., Meulbroke, J.A., Staas, J.K., Gilley, R.M. and Tice, T.R.
(1990). Controlled vaccine release in the gut associated lymphoid tissue I. orally
administered biodegradable microspheres target the Payer’s patches. J. Control.
Release, 11,205-214.
EI-Hag Ali Said, A. (2005). Radiation synthesis of interpolymer polyelectrolyte complex and
its application as a carrier for colon-specific drug delivery system. Biomaterials,
26, 2733-2739.
El-Kamel, A.H., Sokar, M,S.,A1 Gamal, S.S., Naggar, V.F. (2001). Preparation and evaluation
of ketoprofen floating oral delivery system. Int. J. Pharm., 220, 13-21.
Fagerberg, S.E. (1982). The effects of a bulk laxative (Metamucil) on fasting blood glucose,
serum lipids and other variables in constipated patients with non-insulin
dependent adult diabetes. Curr. Ther. Res., 31,166-172.
Fasano, A. (1998). Novel approaches for oral delivery of macromolecules. J.Pharm. Sci,, 87,
329-334.
Chapter 7 _ _________ __ ________________________References
Jamia Hamdard 230
Chapter 7 ____________ References
Fattah, E.A.E., Grant, D.J.W., Gabr, K.E., Meshali, M.M, (1998). Physical characteristics and
release behavior of salbutamol sulfate beads prepared with different ionic
polysaccharides. Drag Dev, Ind. Pharm., 24 (6) 541-547.
Fernandez-Banares, F., Hinojosa, J., Sanchez-Lombrana, J.L., Navarro, E., Martinez-
Salmeron, ,f.F., Garcia-Puges, A., Gonzalez-Huix, F., Riera, J,, Gonzalez-Lara, V.,
Domiiiguez-Abascal, F,, Gine, J.J., Moles, J., Gomollon, F,, Gassull, M.A. (1999).
Randomized clinical trial of Plantago ovate seeds (dietary fiber) as compared
with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for
the Study of Crohn’s Disease and Ulcerative Colitis (GETECCU), Am. J.
Gastroenterol., 94, 427-433.
Fischer, H.M., Nanxiong, Y., Ralph, R.G.J., Andersond, L., Marietta, J.A. (2004). The gel-
forming polysaccharide of psyllium husk {Plantago ovata Forsk). Carbohydrate
Res., 339, 2009-2017.
Florholmen, J., Arvidsson-Lenner, R., Jorde, R., Burhol, P.G. (1982). The effect o f
Metamucil on postprandial blood glucose and plasma gastric inhibitory peptide in
insulin-dependent diabetics. Acta Med. Scand., 212, 237-239.
Fourie, B., Pillai, G. C,, Melleron, H., Sinith, P., Panchangnula, R., Ellard, G., Spinaci, S.,
Blomberg, B. (1999). Establishing the bioequivalence of rifampicin in fixed dose
combination containing isoniazid with/or without pyrazinaraide and/or ethambutol
compared to the single drug reference preparations administered in loose
combination: model protocol. WHO/CDS/TB/99., WHO, Geneva, 274.
Fukagawa, N.K., Anderson, J.W., Hageman, G., Young, V.R., Minaker, K.L. (1990). High-
carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy
young and old adults. Am, J. Clin. Nutr., 52, 524-528.
Gabor, F., Wirth, M., Jurkovich, B., Haberl, I., Theyer, G., Walcher, G., Hamilton, G. (1997).
Lectin mediated bioadhesion: proteolytic stability and binding characteristics o f
wheat germ agglutinin and Solamm tuberosum lectin on Caco-2, HT-29 and
human colonocytes. J. Control. Release, 49, 27-37.
Jamia Hamdard 231
Gansbeke, B.V., Timmermans, J., Schoutens, A., Moes, A i. (1991), Intragastric positioning
o f tw o concuiTentiy ingested pharmaceutical m atrix dosage forms. Nucl. Med.
Biol., 18,711-718.
Gaserod, 0., Jolliffe, I.G., Hampson, F.C., Dettmar, P.W., Skjak-Braek, G. (1998). The
enhancement of the bioadhesive properties of calcium alginate beads by coating
with chitosan. Int. J. Pharm., 175 (2), 237-246.
Gasper, M.M., Neves, S., Portaels, F., Pedrosa, J., Silva, M.T., and Cruz, M.E. (2000).
Therapeutic efficacy of liposomal rifabutine in a Mycobacterial avium model o f
infection. Antimicrob. Agents Chemother., 44, 2424-2430,
Gombotz, W.R., Wee, S.F. (1998), Protein release from alginate matrices. Adv. Drug Deliv.
Rev., 31 (1-2) 267-285.
Good, R,J. (1977). Surface free energy of solids and liquids; themiodynamics, molecular
forces, and structures. J. Colloid Interface Sci., 59, 398-419.
Goyal, P., Pandey, S., Udupa, N, (2002). Simultaneous spectrophotoraetric estimation o f
isoniazid and rifampicin from combined dosage forms. Ind. J. Pharm. Sci,, 76-78.
Gu, J.M., Robinson, J.R., Leung, S.H.S. (1988). Binding of acrylic polymers to
mucin/epithelial surfaces: Structure-property relationships. Crit. Rev. Therap,
Drug Carrier Syst., 5(1), 21-67.
Guo, Qian., Steve, W., Cui, Q,, Wang, J., Christopher, Young. (2008). Fractionation and
physicochemical characterization of psyllium gum. Carbohydrate Polymers, 73,
35-43.
Gupta, K.C., Jabrail, F.H. (2007). Gluteraldehyde cross-linked chitosan microspheres for
controlled release of centchroman. Carbohydrate Res., 342, 2244-2252,
Gupta, R.R,, Argawal, C.G., Singh, G.P., Ghatak, A. (1994). Lipid-lowering efficacy of
psyllium hydrophilic mucilloid in non insulin dependent diabetes mellitus with
hypercholesterolemia. Indian J. Med. Res., 100, 237-241.
Chapter 7_________________________________________________________ References
Jamia Hamdard 232
Haas, J., Lehr, C.M, (2002). Developments in the area of bioadhesive drag delivery systems.
Expert Opin, Biol. Ther., 2, 287-298.
Haltner, E., Easson, Lehr, C.M. (1997). Lectins and bacterial invasion factors for
controlling endo and transcytosis of bioadhesive drug carrier systems. Eur. J.
Pharm. Biopharm., 44, 3-13.
Helfand, E. and Tagami, Y. (1972a). Theoiy of interface between immiscible polymers. J,
Chem. Phys.,57, 1812-1813.
Helfand, E. and Tagami, Y. (1972b). Theory of the interface between immiscible polymers.
II. J. Chem. Phys., 56, 3592-3601.
Higuchi, T, (1963). Mechanism of sustained action medication, theoretical analysis o f rate o f
release of solid drugs dispersed in solid matrices. J. Pharm. Sci., 52, 1145-1149.
Hixson, A.W., Crowell, J.H. (1993). Dependence of reaction velocity upon surface and
agitation (1) theoretical consideration. Ind. Eng. Chem., 23, 923-931.
Holmes, A. and Gamer, P. (1999). Tuberculosis. Clin. Evid. 1, 1-7,
Horowitz, M.L and Pigman, W. (1977). The Glycoconjugates, Vol. 1, Academic Press, New
York, 423-440.
Hosny, E.A., Al-Helw, A.A.M. (1998). Effect of coating o f aluminum
carboxymethylcellulose beads on the release and bioavailability of diclofenac
sodium. Pharm. Acta Helv., 72 (5) 255-261.
Huntsberger, J.R. (1967). Mechanism of adhesion. J. Paint Technol., 39,199-211.
Huntsberger, J.R. (1966), In; R.L. Patrick (Eds.), Treatise on adhesion and adhesives, Vol. 1,
Marcel Dekker, New York, pp. 119-150.
Ikeda, K,, Murata, K., Kobayashi, M., Noda, K. (1992). Enhancement o f bioavailability of
dopamine v/a nasal route in beagle dogs. Chem.Pharm. Bull., 40, 2155-2158.
Chapt^T^^ ^ ___________________________________________________________________ ______________________ References
Jamia Hamdard 233
Indian Pharmacopoeia, (2007a). Published by the Indian Pharmacopoeia Commission,
Ministry of Health and Family Welfare, Govt, o f India, Ghaziabad, Vol. 2,
pp. 1247-1248.
Indian Pharmacopoeia. (2007b), Published by the Indian Pharmacopoeia Commission,
Ministiy of Health and Family Welfare, Govt, o f India, Ghaziabad, Vol. 2, p. 24.
Indian Pharmacopoeia. (2007c). Published by the Indian Pharmacopoeia Commission,
Ministry of Health and Family Welfare, Govt, o f India, Ghaziabad, Vol. 2,
pp. 1659-1660.
Indian Pharmacopoeia. (2007d). Published by the Indian Pharmacopoeia Commission,
Ministry of Health and Family Welfare, Govt, of India, Ghaziabad, Vol. 2, p. 388.
Chapter 7 ......................
International Union Against Tuberculosis and Lung Disease (lUATLD). (2000). Management
of tuberculosis: a guide for low income countries. ed. 68 boulevard Saint-
Michel, Paris, France, pp. 1-117
Jacob, J.S., Mathiowitz, E, (2000). US Pat. No. 6,123,965.
Jain, C.P,, and Vyas, S.P., (1995). Preparation and characterization o f niosomes containing
rifampicin for lung targeting. J. Microencapsul., 12,401-407.
Jain, S. K., Awasthi, A. M., Jain, N. K,, Agrawal, G. P. (2005). Calcium silicate based
microspheres of repaglinide for gasti'oretentive floating drug delivery; Preparation
and in vitro characterization. J, Control. Release, 107, 300- 309.
Jindal, K.C., Chaudhary, R,S,, Singla, A,K., Gangwal, S.S,, Khanna, S. (1994). Dissolution
test method for rifampicin-isoniazid fixed dose formulations. J. Pharm. Biomed.
Anal, 12(4), 493-497.
Joseph, N.J., Lakshmi, S., Jayakrishnan, A. (2002). A floating-type oral dosage form for
piroxicam based on hollow polycai’bonate microspheres: in vitro and in vivo
evaluation in rabbits. J. Control. Release, 79, 71-79.
Kaelble, D.H. (1974). A relationship between the fracture mechanics and surface energy
failure criteria. J, Appl. Polym. Sci. 18,1869.
Jamia Hamdard 234
Kamatli, M.P„ Shenoy, B.D., Tiwari, S,B., Karki, R., and Udupa, N. (2000). Prolonged
release biodegradable vesicular earners for rifampicin formulation and kinetics of
release, Ind. J. Exp. Biol., 38, 113-118.
Kamath, R., Kalpana, Park, Kinain. (1995). Mucosal Adhesive preparations. In: Encyclopedia
of Pharmaceutical Technology. Mercel & Dekker, 12, pp. 132-162.
Kainmer, H.W. (1983). Adhesion between polymers-Review, Acta Polymerica, 34: 112-118.
Karajgi, J., Jain, N.K., Vyas, S.P. (1993). Passive vectoring of a colloidal carrier system for
sodium stibogluconate, preparation, charecterization and performance evaluation.
J. Drug Target., 1, 197-206.
Katchalsky, A., Cooper, R.E., Upadhyay, J., Wassermann, A. (1961). Counter-ion fixation in
alginates. J. Chera. Soc., 12, 5198-5204.
Kennedy, J.F., Sandhu, J.S., Southgate, D.A.T. (1979). Structural data for the carbohydrate of
ispaghula husk ex Plantago ovata Forsk. Carbohydrate Res., 75, 265”274.
Khotimchenko, Y.S., Kovalev, V.V., Savchenko, O.V., Ziganshina,O.A. (2001). Physical-
chemical properties, physiological activity, and usage of alginates, the
polysaccharides of brown algae. Russian Journal o f Marine Phamacology, 27,
S53-S63.
Kibbe, A.H, (2005). Pharmaceutical Excipients. Edited by: Raymond C. Rowe, Paul J.
Sheskey and Sian C. Owen, pp, 2033-2040.
Kinloch, A.J. (1980). The science of adhesion: I. Surface and interfacial aspects. J. Mater.
Sci., 15,2141-2166.
Kriwet, B., Kissel, T. (1996). Interactions between bioadhesive poly (aciylic acid) and
calcium ions. Int. J. Phami., 127, 135-145.
Labana, S., Pandey, R., Sharma, S., Kliullar, G.K. (2002), Chemotherapeutic activity against
murine tuberculosis of once weekly administered drags (isoriiazid and rifampicin)
encapsulated in liposomes. Int. J. Antimicrob. Agents, 20, 301-304.
Chapter 7 ________________________ _________ ^ ___________________________
Jamia Hamdard 235
Labat-Robert, J, and Decaeus, C. (1979). Gastric mucus glycoproteins: Structure, functions
and pathology. Pathol. Biol. (Paris), 27(4), 241-247.
Laidlaw, R.A., Purcival, E.G.V. (1950). Studies of seed mucilages. Part V. Examination o f a
polysaccharide extracted from the seeds of Plantago ovata Forsk by hot water. J.
Chem. Soc„ 528-534.
Lee, J. H., Park, T. 0 ., Choi, H, K. (1999). Development of oral drug delivery system using
floating microspheres. J. MicroencapsuL, 16, 715- 729.
Lee, J.W., Park, J.H., Robinson, J.R. (2000), Bioadhesive based dosage forms: the next
generation, J, Pharm, Sci., 89, 850-866.
Lehr, C,M., Bouwstra, J.A., Kok, W., Noach, deBoer, A.G., Junginger, H.E. (1992).
Bioadhesion by means of specific binding of tomato lectin. Pharm. Res., 9, 547-
553.
Lehr, C.M., Bowstra, J.A., Tukker, J.J., Junginer, H.F, (1990), Intestinal transit time of
bioadhesive microspheres in an in situ loop in the rat. J. Control, Release, 13, 51-
61.
Lele, B.S,, Hofftnan, A.S. (2000). Mucoadhesive drug carriers based on complexes of
poly (aery lie acid) and PEGylated drugs having hydrolysable PEG-anhydride-
drug linkages. J. Control. Release, 69,237-248.
Lenearts, V. and Gurny, R. (1990). Bioadhesive Drug Delivery Systems. CRC Press, Boca
Raton, FL, pp. 93-104.
Li, S„ Lin, S., Daggy, B.F., Mirchandani, H.L., Chien, T.W. (2002). Effect o f fonnulation
variables on the floating properties of gastric floating drug delivery system. Drug.
Dev. Ind. Pharm,, 28, 783-793.
Liu, X,D„ Bao, D.C., Xue, W.M., Xiong, Y., Yu, W.T., Yu, X.J., Ma, X.J., Yuan, Q. (2002a).
Preparation of uniform calcium alginate gel beads by membrane emulsification
coupled with internal gelation. J. Appl. Pol. Sci., 87, 848-852.
C h a ^ i ^ __ _____________________ ____________________________________References
Jamia Hamdard 236
Liu, X.D., Yu, W.Y., Zhang, Y„ Xiie, W.M., Yu, W.T., Xiong, Y„ Ma, X J., Chen, Y., Yuan,
Q. (2002b). Characterization of structure and diffusion behaviour of Ca-alginate
beads prepared with external or internal calcium sources. J. MicroencapsuL, 19,
775-782.
Long, M.W., Snider, D.R., Farer, L.S, (1979). US Public health service cooperative trial o f
three rifampicin-isoniazid regimens in the treatment of pulmonary tuberculosis.
Am. Rev, Respire. Dis., 119, 879-894,
Lopes, E,, Pohlniann, A.R., Bassani, V. and Gurteress, S.S. (2000). Polymeric colloidal
system containing ethionamide: preparation and physiochemical characterization.
Pharmazie, 55, 527-530.
Lordi, G and Reichman, L (1999). Tuberculosis. Cuit. Pract. Med., 2, 621-626.
Lucinda-Silva, R.M., and Evangelista, R.C. (2003). Microspheres o f alginate-chitosan
containg isoniazid, J. Microencapsui,, 20, 145-152.
Maincent, P., Le Verge, R., Sado, P., Couveur, P. and Devissaguet, J.P, (1986). Disposition
kinetics and oral bioavailability of vincamin-loaded polycyanoacrylate
nanoparticles. J. Phann. Sci., 75, 955-958.
Malmstern, M. (2002). Polymer particles. In: Surfactants and polymers in drug delivery.
Marcel Dekker, New York, pp. 271 -290.
Mariappan, T.T., Geetha, Thiraviam., Pandey, Rajesh., Jindal, K.C., Singh, Saranjit, (2004).
Interference of isonicotinyl hydrazone in the microbiological analysis of
rifampicin from anti-tuberculosis FDC products containing isoniazid. J. Phann.
Biomed. Anal, 36, 643-647.
Martin, A. (1991). Physical Pharmacy. Lea Febiger, Philadelphia, IV '' ed., pp. 423- 451.
Maurizio, R., Giovagnoli, S., Blasi, P., Schoubben, A., Perioli, L., Rossi, C. (2006).
Development of liposomal capreomycine sulphate formulation: Effect of
formulation variables on peptide encapsulation. Int. J. Pharm., 311, 172-188.
Chapter? ^ ^ ____________________ ______ ^ _________________________ R e fe re n ts^
Jamia Hamdard 237
Mikos, A.G. and Peppas, N.A. (1986). Systems for controlled-release of drugs. V.
Bioadhesive systems. S.T.P. Phanna., 2, 705-716,
Mirghani, A., Idkaidek, N.M., Salem, M.S., Najib, N.M. (2000). Formulation and release
behavior of diclofenac sodium in compritol 888 matrix beads encapsulated in
alginate. Drug Dev. Ind. Pharm., 26 (7), 791-795,
Mislira, B., .fayanth, P. and Sankar, C. (2003). Development of chitosan-alginate
microcapsules for colon speci fic delivery of metronidazole. Indian Drugs, 40 (12),
695-700.
Mojaverian, P.,VIasses, P.M., Kellner, P.E.,Rocci Jr., M.L. (1988). Effects of gender, posture,
and age on gastric residence time of an indigestible solid: Phantiaceutical
considerations. Pharm. Res., 10, 639-644.
Moreyra, A.E., Wilson, A.C., Koraym, A, (2005), Effect o f combining psyllium fiber with
simvastatin in lowering cholesterol. Arch. Int, Med, 165,1161-1166.
Mulye, N.V. and Turco, S.J. (1995), A simple model based on first order kinetics to explain
release of highly water soluble drugs from porous dicalcium phosphate dihydrate
matrices. Drug Dev. Ind. Pharm., 21, 943-953.
Oliver, S.D. (2000). The long-term safety and tolerability of ispaghula husk. J. R. Soc. Health,
120, 107-111.
0th, M., Franz, M., Timmermans, J., Moes, A.J. (1992). The bilayer floating capsule: A
stomach-directed drug delivery system for misoprostol. Pharm. Res., 9, 298-302.
Pandey, R. and Khullar, G.K. (2004a). Chemotherapeutic potential o f alginate-chitosan
microspheres as anti-tubercular drug carriers. J. Antimicrob. Chemother., 53, 635-
640.
Pandey, R. and Khullar, G.K. (2004b). Subcutaneous nanoparticle-based antitubercular
chemotherapy in an experimental model. J. Antimicrob, Chemother., 54(1):266-
268.
7 _______ References
Jamia Hamdard 238
Pandey, R., Sharma, S., Zahoor, A., Khullar, G.K. (2003b). Nanoparticles encapsulated
antitiibercular drags as a potential oral drug delivery system against murine
tuberculosis. Tuberculosis (Edinb.), 83, 373-378.
Pandey, R,, Sharma, S., Zahoor, A., Sharma, A., Kliullar, G.K. and Prasad, B. (2Q03a). Poly
(DL-lactide-co-glycolide) nanopaiticles based inhalable sustained drug delivery
system for experimental tuberculosis. J. Antimicrob. Chemother., 52, 981-986.
Park, H, and Robinson, J.R. (1985). Physico-chemical properties of water insoluble polymers
important to mucin/epithelial adhesion. J. Control. Release, 2, 47-57.
Pass!, W.J. (1989). Synthetic polymers in modern pharmacy. Prog. Polym. Sci., 14 (5), 629-
677,
Pastors, J.G., Blaisdell, P.W., Balm, T.K., Asplin, C.M., Pohl, S.L, (1991). Psyllium fiber
reduces rise in postprandial glucose and insulin concentrations in patients with
non-insulin-dependent diabetes. Am. J. Clin. Nutr., 53, 1431-1435.
Patel, J.K., Patel, R.P., Amin, A.F., Patel, M.M. (2005). Fonnulation and evaluation of
mucoadhesive glipizide microspheres. AAPS PharmSciTech, 6: E49-55.
Peppas, N.A, and Buri, P.A. (1985). Surface, interfacial and molecular aspects of polymer
bioadhesion on soft tissues. J. Control. Release, 2, 257-275.
Pigman, W. and Gottschalk, A.(1966). In: A, Gottschalk (Eds.), Glycoproteins: Their
Composition, Structure and Function, Vol. 5, Elsevier, Amsterdam, pp. 434-445.
Pittler, M.FI., Ernst, E. (2004). Dietary supplements for body-weight reduction: a systematic
review. Am. J. Clin. Nutr., 79, 529-536.
Poncelet, D., Babak, V., DuHeu, C,, Picot A. (1999). A physico-chemical approach to
production of alginate beads by emulsification-intemal ionotropic gelation.
Colloids and Surfaces A: Pliysiochemical and Engineering Aspects, 155, 171-
176.
Chapter 7_ ___ References
Jamia Hamdard 239
Poncelet, D,, Lencki, R„ Beaulieu, C., Halle, J,P., Neufeld, R.J., Fournier, A. (1992).
Production of alginate beads by emulsification/internal gelation. I. Methodology.
Applied Microbiology & Biotechnology, 38, 39-45.
Ponchel, G, and Duchene, D. (1991), In: M, Szycher (Eds.), High Performance Biomaterials,
Technomic, Lancaster, PA, pp. 231 -242.
Ponchel, G., Touchard, F., Duchene, D., Pappas, N.A. (1987). Bioadhesion analysiws of
controlled-release systems. I. Fracture and interpenetration analysis in
poiy(acryIic acid)-containing systems, J. Control. Release, 5, 129--141.
Quenelle, D.C., Winchester, G.A., Staas, J.K., Barrow, E.L.W. and Barrow, W.W. (1999).
Efficacy of microencapsulated rifampicin in Mycobacterium tuberculosis-infected
mice. Antimicrob. Agents Chemother., 43, 1144-1151.
Quenelle, D.C., Winchester, G.A., Staas, J.K., Barrow, E.L.W. and Baixow, W.W. (2001).
Treatment of tuberculosis using a combination of sustained-release rifampicin-
loaded microspheres and oral dosing with isoniazid. Antimicrob. Agents
Chemother., 45,1637-1644.
Rajinikanth, F.S., Sankar, C., Mishra, B. (2003). Sodium alginate microspheres o f metoprolol
tartarate for iiitranasal systemic delivery; development and evaluation. Drug D el,
10,21-28,
Ramkumar, D., Rao, S.S, (2005). Efficacy and safety of traditional medical therapies for
chronic constipation: systematic review. Am. J, Gastroenterol, 100, 936-971.
Ranga Rao, K.V. Buri, P. (1988), Bioadhesion and factors affecting the bioadhesion of
microparticles. In: M. Szycher (Eds.), High Performance Biomaterials, Lancaster
PA, Technomic Publishing Company, New York, pp. 259-268
Raviglione, M, and O’Brien, R. (1998). Tuberculosis. In: Harrison’s principles o f internal
medicine, Fauci, A,S„ Braunwald, E., Isselbacher, K. J, (Eds.), Me Graw Hill,
New York, 1004-1014.
Chapter 7 ____ References
Jamia Hamdard 240
Chapter 7 _________________ References
Rodriguez-Moraa, M., Guerrero-Romero, F., Lazcano-Burciaga, G. (1998). Lipid and
glucose-lowering efficacy of Plantago psyllium in type II diabetes. J, Diabetes
Compiicat. 12, 273-278,
Romero, A.L., West, K.L., Zern, T., Fernandez, M.L, (2002). The seeds from Plantago ovata
lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs. J.
Nutr,, 132,1194-1198.
Rouge, N., Aliemann, E., Gex-Fabry, M. (1997). Comparative phannacokinetic study o f a
floating multiple unit capsule, a high density multiple unit capsule and an
immediate release tablet containing 25mg atenolol. Pharm. Acta. Helv., 73, 81-87.
Rouge, N., Leroux, J.C., Cole, E.T., Doelker, E., Buri, P. (1997). Prevention of the sticking
tendency of floating minitablets filled into hard gelatin capsules. Eur. J. Pharm.
Biophami,, 43,165-171.
Sandhu, J.S., Hudson, G.J., Kennedy, J.F. (1981). The gel nature and stmcture o f the
carbohydrate of ispaghula husk ex Plantago ovata Forsk. Carbohydrate Res., 93,
247-259.
Santos, C.A,, Jacob, J.S., Hertzog, B.A., Carino, G.F., Mathiowitz, E. (2000). US Pat. No.
6,156,348.
Sato, Y., Kawashima, Y., Takeuchi, H., Yamamoto, H. (2003). Physicochemical properties to
detennine the buoyancy of hollow microspheres (microballons) prepared by the
emulsion solvent diffusion method, Eur. J. Phami. Biopharm., 55,297-304.
Scawen, M, and Allen, A, (1977). The action o f proteolytic enzymes on the glycoprotein from
pig gastric mucus. J. Biochem., 163(2) 363-368,
Sethuraman, V.V,, and Hickey, A.J. (2002). Powder properties and their influence on dry
powder inhaler delivery of an antitubercular drug. AAPS PharmSciTech, 3, 28-34.
Sharma, R., Saxena, D., Dwivedi, A.K. and Misra, A. (2001), Inhalable microsphere
containing drug combinations to target alveolar macrophages for treatment of
pulmonary tuberculosis. Pharm. Res., 18, 1405-1410.
—Jamia Hamdard 241
Shilpa, A., Agrawai, S. S., Ray, A. R. (2003), Controlled delivery o f drugs from alginate
matrix. J. Macromolecular Science part C-Polymer Reviews. 43 (2) 187-221.
Shi'shoo, C.J., Shah, S.A., Rathod, I.S., Salve, S.S., Vora, M.J. (2001). Impaired
bioavailability of rifampicin in presence of isoniazid from fixed dose combination
(FDC) formulation. Int. J. Pharm., 228, 53-67.
Singh, B,, Chauhan, G.S., Bhatt, S.S., Kumar, K. (2006). Metal ion sorption and swelling
studies of psyllium and acrylic acid based hydrogels. Carbohydrate Polym., 64,
50-56.
Singh, B.M., Kim, K,H. (2000). Floating dmg deliveiy systems: an approach to oral
controlled drug delivery via gastric retention. J. Control. Release, 63 (1-2), 235-
259.
Singh, S., and Mohan, B. (2003). A pilot stability study on four fixed-dose combination ajiti-
tuberculosis products. Int. J. Tuberc. Lung Dis., 7, 298-303.
Singh, S., Bhutani, H., Mariappan, T.T., Kaur, H., Bajaj, M., Pakhale, S.P. (2002). Behaviour
of uptake of moisture by drugs and excepients under accelerated conditions o f
temperature and humidity in the absence and presence o f light. 1. Pure anti
tuberculosis drugs and their combinations. Int. J. Pharm. 245, 37-44.
Singh, S., Mariappan, T.T., Sankar, R., Sharda, N, and Singh, B. (2001), A critical revievi o f
the probable reasons for the poor/variable bioavailability o f rifampicin from the
ant-tubercular fixed dose combination (FDC) products, and the likely solutions to
the problem. Int. J. Phami,, 228, 5-17,
Singh, S,, Mariappan, T,T,, Sharda, N., Singh, B. (2000). Degradation of rifampicin, isoniazid
and pyrazinamide from prepared mixtures and marketed single and combination
products under acid conditions. Pharm. Pharmacol. Commun., 6,491-494.
Skidan, I.N., Gel’perina, S.E. and Guliaev, A.E. (2003). Enhanced activity of rifampicin
loaded polybutylcyanoacrylate nanoparticles in relation to intracellularly localized
bacteria. Antibiot. Khimother,, 48, 23-26.
Spiro, R.G,(1970). Glycoproteins. Annual Review of Biochemistry, 39, 599-638.
Chapter 7 References
Jamia Hamdard 242
Suarez, S., O’Hara, P., Kazantseva, M,, Newcomer, C.E., Hopfer, R., Me Murray, D.N. and
Hickey, A.J. (2001). Aiways delivery of rifampicin microparticles for the
treatment of tuberculosis. J. Antimicrob. Chemother., 48, 431-434.
Sultana, Y., Mall, S., Maurya, D. P., Kumar, D., Das, M. (2009), Preparation and in vitro
characterization of diltiazem hydrochloride loaded alginate microspheres. Pharrn.
Dev. Tech., 14(3), 321-331.
Tabor, D. (1977). Surface forces and surface interactions. J. Colloid Interface Sci., 58, 2-13.
Takka, S., Ocak, O.H., Acarturk, F. (1998). Formulation and investigation of nicardipine HCl-
alginate gel beads with factorial design based studies. Ear. J. Pharm. Sci., 6 (3)
241-246.
Talukder, R., Fassihi, R. (2004). Gastroretentive delivery systems: a mini review . Drug. Dev.
Ind. Pharm., 3 0 ,10I9-I028.
ThrolU'H., Freitas, J.E., Swanso, D. (1976). Clinical composition o f cardiac blood pool
visualization with ‘‘’"’Tc HAS. J. Nucl, Med., 19, 796-803.
Timmermans, J., Andre, J.M. (1994), Factors controlling the buoyancy and gastric retention
capabilities of floating matrix capsules: new data for reconsidering the
controversy. J. Phann, Sci., 83,18-24.
Timmermans, J., Gansbeke, V.B., Moes, A.J. (1989). Assessing by gamma scintigraphy the in
vivo buoyancy of dosage forms having known size and floating force profiles as a
function of time. Proceedings of the 5 '’ International Conference on Pharmacy
Technology. Paris, France APGI. 1, pp. 42-51.
Timmermans, J,, Moes, A..1, (1990). How well do floating dosage fonns float. Int. J. Pharm.,
62,207-216.
Tonnesen, H. FI., Karlsen, J. (2002). Alginate in drug delivery systems. Drug Dev. Ind.
Pharm., 28(6), 621-630.
Tsapis, N,, Bennett, D., O’Driscoll, K., Shea, K., Lipp, M.M., Fu, K., Clarke, R.W., Deaver,
D., Yamins, D„ Wright, J., Peloquin, C.A., Weitz, D.A., and Edwards, D.A.
Chapter 7 ___ ^ ______ References
jamia Hamdard 243
(2003). Direct lung delivery of para-aminosalicylic acid by aerosol particles.
Tuberculosis (Edinb.)., 83, 379-385.
Umamaheshwari, R.B., Jain, vS., Bhadra, D„ Jain, N.K. (2003). Floating microspheres bearing
acetohydroxairiic acid for the treatment o f Helicobacter pylori. J. Phanti.
Pharmacol., 55 (12), 1607-1613.
Varelas, C.G., Dixon, D.G and Steiner, C. (1995). Zero order release from biphasic polymer
hydrogels. J. Control. Release, 34, 185-192.
Volkheimer, G. and Schultz, F.H. (1968). The phenomenon of persoiption. Digestion., 1, 213-
218.
Voyutskii, S. S. (1963). Autohesion and adhesion of high polymers-Polymer Reviews, Nark,
FI. F. and Immergut, E, H. (Eds.), Vol. 4, Hiley, New York, pp.74-80.
Vyas, S.P., Kannan, M.E., Jain, S., Mishra, V., aiid Singh, P.(2004). Design o f liposomal
aerosols for improved delivery of rifampicin macrophages. Int. J. Pharm., 269, 37-
49.
Washington, N,, Harris, M., Mussellwhite, A., Spiller, R.C. (1998). Moderation of lactulose-
induced diarrhoea by psyllium: effects on motility and fermentation. Am, J. Clin.
Nutr., 67,317-321.
Whitehead, L., Fell, J,T., Collett, J.H., Sharnia, H.L., Smith, A.M. (1998). Floating dosage
forms: An in vivo study demonstrating prolonged gastric retention. J. Control.
Release, 55, 3-12.
World Health Organization (WHO). (1993). WHO declares tuberculosis a global emergency.
Soz-Praevmed., 38, 25!-252.
World Health Organization (WHO). (2003). Treatment of tuberculosis. Guidelines for
National Programmes. WHO/CDS/TB 2003, 3'' ed., Geneva, Switzerland, WHO,
313.
World Health organization. (1994). TB a global emergency, WHO TB programme. Geneva:
Switzerland.; WHO/TB/94,177:1-28.
Chapter ? References
Jamia Hamdard 244
Yang, L., Fassihi, R. (1996). Zero order release kinetics from self correcting floatable
configuration drug delivery system. J. Pharm. Sci., 85,170-173.
Yang, Ming-shi., Cui, Fu-de,, You, Ben-gang., Fan, Yu-ling,, Wang, Liang., Yue, Peng.,
Yang, He. (2003). Preparation of sustained-release nitrendipine microspheres with
Eudragit RS and Aerosii using quasi-emulsion solvent diffusion method. Int. J.
Pharm., 259,103~-113.
Zaiioor, A., Sharma, S., Khullar, G.K, (2005). Inhalable alginate nanoparticles as
anti tubercular drug carriers against experimental tuberculosis. Int. J. Antimicrob.
Agents, 26 (4), 298-303.
Zhang, W., Jiang, X„ Hu, J., and Fu, C. (2000). Rifampicin polylactic acid microspheres for
lung targeting. J. Microencapsul,, 17, 785-788.
Ziyaur, R., Kanchan, K., Kiiar, R.K., IVfushir, A., Charoo, N.A. (2006). Charad’terization of 5-
fluorouracil microspheres for colonic delivery. AAPS PharmSciTech, 2006; 7 (2)
Article 47 (http://www.aapspharmscitech.org).
Chapter 7 _________ _______________ ____ __ ____________________ References
Jamia Hamdard 245